Literature DB >> 26008862

Exome sequencing identifies complex I NDUFV2 mutations as a novel cause of Leigh syndrome.

Jessie M Cameron1, Nevena MacKay2, Annette Feigenbaum3, Mark Tarnopolsky4, Susan Blaser5, Brian H Robinson6, Andreas Schulze7.   

Abstract

BACKGROUND: Two siblings with hypertrophic cardiomyopathy and brain atrophy were diagnosed with Complex I deficiency based on low enzyme activity in muscle and high lactate/pyruvate ratio in fibroblasts.
METHODS: Whole exome sequencing results of fibroblast gDNA from one sibling was narrowed down to 190 SNPs or In/Dels in 185 candidate genes by selecting non-synonymous coding sequence base pair changes that were not present in the SNP database.
RESULTS: Two compound heterozygous mutations were identified in both siblings in NDUFV2, encoding the 24 kDa subunit of Complex I. The intronic mutation (c.IVS2 + 1delGTAA) is disease causing and has been reported before. The other mutation is novel (c.669_670insG, p.Ser224Valfs*3) and predicted to cause a pathogenic frameshift in the protein. Subsequent investigation of 10 probands with complex I deficiency from different families revealed homozygosity for the intronic c.IVS2 + 1delGTAA mutation in a second, consanguineous family. In this family three of five siblings were affected. Interestingly, they presented with Leigh syndrome but no cardiac involvement. The same genotype had been reported previously in a two families but presenting with hypertrophic cardiomyopathy, trunk hypotonia and encephalopathy.
CONCLUSION: We have identified NDUFV2 mutations in two families with Complex I deficiency, including a novel mutation. The diagnosis of Leigh syndrome expands the clinical phenotypes associated with the c.IVS2 + 1delGTAA mutation in this gene.
Copyright © 2015 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complex I; Exome sequencing; Leigh syndrome; Mitochondria; NDUFV2

Mesh:

Substances:

Year:  2015        PMID: 26008862     DOI: 10.1016/j.ejpn.2015.05.002

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  13 in total

Review 1.  Riboflavin in Neurological Diseases: A Narrative Review.

Authors:  Domenico Plantone; Matteo Pardini; Giuseppe Rinaldi
Journal:  Clin Drug Investig       Date:  2021-04-22       Impact factor: 2.859

Review 2.  Neuromitochondrial Disorders : Genomic Basis and an Algorithmic Approach to Imaging Diagnostics.

Authors:  Santhakumar Senthilvelan; Sabarish S Sekar; Chandrasekharan Kesavadas; Bejoy Thomas
Journal:  Clin Neuroradiol       Date:  2021-06-09       Impact factor: 3.649

3.  Evidence in disease and non-disease contexts that nonsense mutations cause altered splicing via motif disruption.

Authors:  Liam Abrahams; Rosina Savisaar; Christine Mordstein; Bethan Young; Grzegorz Kudla; Laurence D Hurst
Journal:  Nucleic Acids Res       Date:  2021-09-27       Impact factor: 16.971

4.  Identification of homocysteine-suppressive mitochondrial ETC complex genes and tissue expression profile - Novel hypothesis establishment.

Authors:  Ramon Cueto; Lixiao Zhang; Hui Min Shan; Xiao Huang; Xinyuan Li; Ya-Feng Li; Jahaira Lopez; William Y Yang; Muriel Lavallee; Catherine Yu; Yong Ji; Xiaofeng Yang; Hong Wang
Journal:  Redox Biol       Date:  2018-04-04       Impact factor: 11.799

5.  Chlamydomonas reinhardtii as a plant model system to study mitochondrial complex I dysfunction.

Authors:  Nitya Subrahmanian; Andrew David Castonguay; Thea Aspelund Fatnes; Patrice Paul Hamel
Journal:  Plant Direct       Date:  2020-02-03

Review 6.  Molecular Epidemiology of Mitochondrial Cardiomyopathy: A Search Among Mitochondrial and Nuclear Genes.

Authors:  Cristina Mazzaccara; Bruno Mirra; Ferdinando Barretta; Martina Caiazza; Barbara Lombardo; Olga Scudiero; Nadia Tinto; Giuseppe Limongelli; Giulia Frisso
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 6.208

7.  Transient symmetric T2-hyperintensities of basal ganglia and brainstem not only point to Leigh syndrome.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Ann Indian Acad Neurol       Date:  2016 Jul-Sep       Impact factor: 1.383

8.  Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause.

Authors:  Tom E J Theunissen; Minh Nguyen; Rick Kamps; Alexandra T Hendrickx; Suzanne C E H Sallevelt; Ralph W H Gottschalk; Chantal M Calis; Alphons P M Stassen; Bart de Koning; Elvira N M Mulder-Den Hartog; Kees Schoonderwoerd; Sabine A Fuchs; Yvonne Hilhorst-Hofstee; Marianne de Visser; Jo Vanoevelen; Radek Szklarczyk; Mike Gerards; Irenaeus F M de Coo; Debby M E I Hellebrekers; Hubert J M Smeets
Journal:  Front Genet       Date:  2018-10-12       Impact factor: 4.599

Review 9.  Blackout in the powerhouse: clinical phenotypes associated with defects in the assembly of OXPHOS complexes and the mitoribosome.

Authors:  Daniella H Hock; David R L Robinson; David A Stroud
Journal:  Biochem J       Date:  2020-11-13       Impact factor: 3.857

10.  Whole genome and exome sequencing identify NDUFV2 mutations as a new cause of progressive cavitating leukoencephalopathy.

Authors:  Zhimei Liu; Li Zhang; Changhong Ren; Manting Xu; Shufang Li; Rui Ban; Ye Wu; Ling Chen; Suzhen Sun; Matthias Elstner; Masaru Shimura; Minako Ogawa-Tominaga; Kei Murayama; Tieliu Shi; Holger Prokisch; Fang Fang
Journal:  J Med Genet       Date:  2021-04-02       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.